Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05222659 · ClinicalTrials.gov registry record
Perioperative Glucose and Insulin Changes in Major Urologic Surgeries
A clinical trial, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- 20
- Enrollment target
NCT05222659: Completed study, sponsored by University of Kansas Medical Center.
NCT05222659 is a clinical trial that has completed, run by University of Kansas Medical Center. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05222659 has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Urological surgery patients will have their blood glucose measured before, during, and after surgery. Blood glucose will be measured using a continuous glucose monitor (CGM) device. We hypothesize the presence of a hyperglycemic state towards the end of surgery due to increased metabolic demand.
Primary Outcome
Interstitial blood glucose levels measured by Continuous Glucose Monitor (CGM) device, in mg/dL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-04-15 |
| Est. Completion | 2023-01-05 |
What the finished NCT05222659 record still lists
NCT05222659 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05222659 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05222659 about?
NCT05222659 is a clinical study titled "Perioperative Glucose and Insulin Changes in Major Urologic Surgeries". Urological surgery patients will have their blood glucose measured before, during, and after surgery. Blood glucose will be measured using a continuous glucose monitor (CGM) device. We hypothesize the presence of a hyperglycemic state towards the end of surgery due to increased metabolic demand.
What is the current status of trial NCT05222659?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2022-04-15. Estimated completion is 2023-01-05.
Who is sponsoring clinical trial NCT05222659?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI